Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

By P. Gaede, P. Vedel, N. Larsen, G. Jensen, H. Parving, Oluf Pedersen. New England Journal of Medicine, 2003

4,513 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Nephrology

View Paper: https://www.semanticscholar.org/paper/0f57838375fff26cfca215503ba96f0a92b2e584

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

Citations in the corpus

Standards of Medical Care in Diabetes—2014 (2013, background): “An intensive multifactorial cardiovascular risk intervention targeting glucose, blood pressure, lipids, smoking, and other lifestyle factors has been shown to reduce the progression and development of CAN among patients with type 2 diabetes (469).”
Adherence to Therapies in Patients with Type 2 Diabetes (2013, background): “Indeed, multifactorial medication for diabetes and related complications can involve up to 10 tablets per day [33], and there is no doubt that the complexity of treatments has a profound influence on adherence [34].”
Factors Influencing the Decline in Stroke Mortality (2013, background): “This program involved a regimented plan for managing diabetes mellitus, as well as HBP and high cholesterol, and included wellness programs in exercise, smoking cessation, and dietary intervention.(225,226) Collectively, these studies suggest that multifactorial risk factor intervention, especially ”
Diabetes and mortality following acute coronary syndromes. (2007, background): “Reducing coronary risk from diabetes requires a multifactorial approach to manage all atherogenic influences.(38) Longterm, targeted, intensive use of proven therapies for the traditional coronary risk factors must be widely promoted for patients with diabetes, particularly following ACS.”
[Guidelines on the management of stable angina pectoris: executive summary]. (2006, background): “Multifactorial intervention in diabetic patients may indeed reduce both cardiovascular and other diabetic complications markedly.(138) Recently the addition of pioglitizone in addition to other hypoglycaemic medication has been shown to reduce the incidence of death, MI or stroke by 16% in patients ”